# Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/feasibility-of-a-prospective-randomised-open-label-international-multicentre/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lotte E. Elshof,Konstantinos Tryfonidis,Leen Slaets,A. Elise van Leeuwen‐Stok,Victoria Skinner,Nicolas Dif,Ruud M. Pijnappel,Nina Bijker,Emiel J. Rutgers,Jelle Wesseling |
| Citations | 385 |
| DOI | 10.1016/j.ejca.2015.05.008 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.ejca.2015.05.008 |
| OpenAlex ID | https://openalex.org/W1867337880 |
| PMID | 26025767 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Jelle Wesseling](https://scholariq.org/researchers/jelle-wesseling/)

## Paper journal

- [European Journal of Cancer](https://scholariq.org/journals/european-journal-of-cancer/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.